Histogen Inc logo

HSTO - Histogen Inc Share Price

$0.81 -0.0  -4.8%

Last Trade - 23/07/21

Micro Cap
Market Cap £25.8m
Enterprise Value £9.63m
Revenue £1.10m
Position in Universe 6086th / 6995
Unlock HSTO Revenue
Relative Strength (%)
1m -24.8%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -76.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.80 35.4 33.6 11.5 2.06 0.43
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2021, HistogenInc revenues decreased 56% to $431K. Net loss increasedfrom $1.8M to $4.3M. Revenues reflect Professional servicesdecrease of 89% to $12K. Higher net loss reflects Generaland administrative - Balancing increase of 97% to $2.2M(expense), Stock-based Compensation in SGA increase from$88K to $177K (expense), Interest Expense/Income - Netincrease from $0K to $5K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


HSTO Revenue Unlock HSTO Revenue

Net Income

HSTO Net Income Unlock HSTO Revenue

Normalised EPS

HSTO Normalised EPS Unlock HSTO Revenue

PE Ratio Range

HSTO PE Ratio Range Unlock HSTO Revenue

Dividend Yield Range

HSTO Dividend Yield Range Unlock HSTO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
HSTO EPS Forecasts Unlock HSTO Revenue
Profile Summary

Histogen Inc., formerly Conatus Pharmaceuticals Inc., is a regenerative medicine company. The Company is focused on developing technologies that replace and regenerates tissues in the body. The company’s technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address unmet medical needs. The Company has product candidates in clinical development intended to address and offer treatment for hair loss, dermal filler and treatment for joint cartilage repair. The Company manufactures a soluble multipotent cell conditioned media (CCM), which is the starting material for products for hair growth, skin care and other applications. In addition to this, the Company also manufactures an insoluble extracellular matrix (ECM) for applications such as orthopedics, wound care and soft tissue augmentation.

Last Annual December 31st, 2020
Last Interim March 31st, 2021
Incorporated July 13, 2005
Public Since July 25, 2013
No. of Shareholders: 110
No. of Employees: 19
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 41,729,257
Free Float (0.0%)
Eligible for
HSTO Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for HSTO
Upcoming Events for HSTO
Wednesday 11th August, 2021 Estimate
Q2 2021 Histogen Inc Earnings Release
Monday 8th November, 2021 Estimate
Q3 2021 Histogen Inc Earnings Release
Frequently Asked Questions for Histogen Inc
What is the Histogen Inc share price?

As of 23/07/21, shares in Histogen Inc are trading at $0.81, giving the company a market capitalisation of £25.8m. This share price information is delayed by 15 minutes.

How has the Histogen Inc share price performed this year?

Shares in Histogen Inc are currently trading at $0.81 and the price has moved by -73.67% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Histogen Inc price has moved by -80.46% over the past year.

What are the analyst and broker recommendations for Histogen Inc?

Of the analysts with advisory recommendations for Histogen Inc, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Histogen Inc is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Histogen Inc next release its financial results?

Histogen Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Histogen Inc dividend yield?

Histogen Inc does not currently pay a dividend.

Does Histogen Inc pay a dividend?

Histogen Inc does not currently pay a dividend.

When does Histogen Inc next pay dividends?

Histogen Inc does not currently pay a dividend.

How do I buy Histogen Inc shares?

To buy shares in Histogen Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Histogen Inc?

Shares in Histogen Inc are currently trading at $0.81, giving the company a market capitalisation of £25.8m.

Where are Histogen Inc shares listed? Where are Histogen Inc shares listed?

Here are the trading details for Histogen Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: HSTO
What kind of share is Histogen Inc?

Based on an overall assessment of its quality, value and momentum, Histogen Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Histogen Inc share price forecast 2021?

Shares in Histogen Inc are currently priced at $0.81. At that level they are trading at 0.37% discount to the analyst consensus target price of 0.00.

Analysts covering Histogen Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.71 for the next financial year.

How can I tell whether the Histogen Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Histogen Inc. Over the past six months, the relative strength of its shares against the market has been -37.84%. At the current price of $0.81, shares in Histogen Inc are trading at -32.23% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Histogen Inc PE Ratio?

We were not able to find PE ratio data for Histogen Inc.

Who are the key directors of Histogen Inc?

Histogen Inc's management team is headed by:

Steven Mento - DRC
Daniel Ripley - SVP
Edward Smith - SVP
Richard Pascoe - PRE
Gail Naughton - FDR
Martin Latterich - VOP
Thomas Hubka - SEC
David Crean - CHM
Jonathan Jackson - DRC
Brian Satz - DRC
Susan Knudson - CFO
Susan Windham-Bannister - DRC
Rochelle Fuhrmann - DRC
Who are the major shareholders of Histogen Inc?

Here are the top five shareholders of Histogen Inc based on the size of their shareholding:

Lordship Ventures LLC Corporation
Percentage owned: 5.65% (2.36m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 2.06% (859k shares)
Vanguard Total Stock Market Index Fund Mutual Fund
Percentage owned: 1.67% (699k shares)
Naughton (Gail K) Individual Investor
Percentage owned: 1.02% (427k shares)
Vanguard Extended Market Index Fund Mutual Fund
Percentage owned: 0.63% (263k shares)
Similar to HSTO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.